Lanean...
The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
INTRODUCTION: Parkinson’s therapeutic interventions are only symptomatic. An optimal treatment should therefore address the largest number of motor and non-motor symptoms, to manage patients at best. Safinamide is one of the most recent approved drugs for fluctuating patients, in add-on to levodopa,...
Gorde:
| Argitaratua izan da: | Drug Des Devel Ther |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203199/ https://ncbi.nlm.nih.gov/pubmed/34140766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S302673 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|